Letrozolexin – USA

$109.50

Availability: Out of Stock

ACTIVE HALF-LIFE 2 days
TABLET COUNT: 50 COUNTS
 CLASSIFICATION Non-steroidal aromatase inhibitor
 DOSAGE 0.5 – 2.5 mg/day
 ACNE No
 WATER RETENTION No
 HBR No
 HEPATOTOXICITY No
 AROMATIZATION No

Out of stock

SKU: EURO11794-1 Categories: , , ,

Description

Letrozolexin is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozolexin selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells.

Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production.

Letrozolexin is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozolexin are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax.

Letrozolexin has shown to reduce estrogen levels by 98 percent while raising testosterone levels.

The anti-estrogen action of Letrozolexin is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems.

Letrozolexin has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozolexin is used to treat adolescents and children with short stature.

Reviews

There are no reviews yet.

Be the first to review “Letrozolexin – USA”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsLetrozolexin - USA removeLetrozole 2.5mg removeT4(Levothyroxine) 400 MCG removeEq 200 - Odin Pharma removeAnavar 10 - Odin Pharma removeLetrozole - Odin Pharma remove
Image
USA
USA
USA
USA
USA
USA
SKUEURO11794-1RF-Axiom peptides-domestic6562RF-Axiom peptides-domestic7314
Rating
Price$109.50 $42.99 $42.99 $80.99 $120.00 $155.99
Stock

Out of stock

AvailabilityOut of stock
Add to cart

Read more

Add to cart

Add to cart

Add to cart

Add to cart

Add to cart

DescriptionACTIVE HALF-LIFE 2 days TABLET COUNT: 50 COUNTS  CLASSIFICATION Non-steroidal aromatase inhibitor  DOSAGE 0.5 - 2.5 mg/day  ACNE No  WATER RETENTION No  HBR No  HEPATOTOXICITY No  AROMATIZATION NoActive Pharmaceutical Ingredient:Boldenone Undecylenate Pack:10ml vial x 200 mg/ml Form:InjectableActive Pharmaceutical Ingredient:Oxandrolone Pack:100 Tabs x 10 Mg Form:OralActive Pharmaceutical Ingredient:Letrozole Pack:30 Tabs x 2.5 Mg Form:Oral
ContentLetrozolexin is a nonsteroidal inhibitor of estrogen synthesis with antineoplastic activity. As a third-generation aromatase inhibitor, Letrozolexin selectively and reversibly inhibits aromatase, which may result in growth inhibition of estrogen-dependent breast cancer cells. Aromatase, a cytochrome P-450 enzyme localized to the endoplasmic reticulum of the cell and found in many tissues including those of the premenopausal ovary, liver, and breast, catalyzes the aromatization of androstenedione and testosterone into estrone and estradiol, the final step in estrogen biosynthesis. Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Letrozole blocks production of estrogens in this way by competitive, reversible binding to the heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of mineralo- or corticosteroids. In contrast, the antiestrogenic action of tamoxifen, the major medical therapy prior to the arrival of aromatase inhibitors, is due to its interfering with the estrogen receptor, rather than inhibiting estrogen production. Letrozolexin is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Side effects include signs and symptoms of hypoestrogenism. There is concern that long term use may lead to osteoporosis, which is why prescriptions of Letrozolexin are often accompanied by prescriptions of osteoporosis-fighting medication such as Fosamax. Letrozolexin has shown to reduce estrogen levels by 98 percent while raising testosterone levels. The anti-estrogen action of Letrozolexin is preferred by athletes and bodybuilders for use during a steroid cycle to reduce bloating due to excess water retention and prevent the formation of gynecomastia related breast tissue that is a side effect of some anabolic steroids. Usage above 2.5 mg/day is known to potentially temporarily kill sex drive. Above 5mg/day for extended periods may cause kidney problems. Letrozolexin has also been shown to delay the fusing of the growth plates in adolescents. This may boost the effectiveness of growth hormone, and thus Letrozolexin is used to treat adolescents and children with short stature.[vc_row][vc_column][vc_tta_tabs][vc_tta_section title="What is LEVOTHYROXINE?" tab_id="1570618483635-f21441d5-514b"][vc_column_text]Our thyroid gland produces a naturally occurring hormone called levothyroxine- also known as T4. The thyroid hormones in the body consists in the regulation of burning fat, carbohydrates and protein. They are responsible for the amount of the metabolic turnover, which is burned in the resting state during a given period of time. Bodybuilders occasionally use this during the mass phase, to increase the metabolic turnover and burn more calories. Furthermore, bodybuilders take protein preparations and/or Clenbuterol with the use of this hormones to counteract the muscle breakdown. Side effects include trembling, restlessness, dizziness, sweating, weight gain, hair loss, diarrhea, insomnia, nausea, increased heart rate etc.[/vc_column_text][/vc_tta_section][vc_tta_section title="How to Use it?" tab_id="1570618483673-4841df30-c79e"][vc_column_text]Athletes speak of dosages between 200-400 mcg/day of levothyroxine for diet support. Athletes should slowly increased when starting and decreased when ending the cure so the thyroid gland will be adjusted smoothly. The medication usually last 4-6, maximum 8 weeks However, always remember not to take steroids online or other medications if you are pregnant for the cases of women. The doctor must regularly examine you for this possibility. Tell your doctor all of your health conditions as there may some interactions with your current medication of steroids online. Importantly, they should extra supervise you in case you have an existing condition. Lastly, only the doctor or a nurse can administer these steroids online. Your dose depends on your condition and your doctor will decide the dosage. Browse other Peptides, Ancillaries and check the different types of supplements  HERE.[/vc_column_text][/vc_tta_section][/vc_tta_tabs][/vc_column][/vc_row]
Weight
DimensionsN/AN/AN/AN/AN/AN/A
Additional information